NAVIVA GROUP:

NAM HUNG VIET Vaccine & biological joint stock company

TUONG KHUE® Pharmaceutical joint stock company

WINBIO® Joint stock company

SUNMED Investment joint stock company

Total: 99372 Online: 1

Home > News

Gallery & Events

News

Career

08/07/2026

News

NAVIVA Group tăng cường kết nối hợp tác cùng Viện Vắc xin và Sinh phẩm Y tế (IVAC)

23/06/2026

News

CONGRATULATIONS ON THE 20TH ANNIVERSARY OF NAM HUNG VIET VACCINE AND BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

11/06/2026

News

Scientific Symposium Highlights the Latest Recommendations on Varicella Prevention and the Second-Generation MAV/06 Varicella Vaccine

20/05/2026

News

Scientific Symposium: VARICELLA – SECOND-GENERATION MAV/06 VACCINE AND UPDATES FROM THE WORLD HEALTH ORGANIZATION (WHO)

11/05/2026

News

WHY ARE VARICELLA-RELATED HOSPITALISATIONS STILL INCREASING DESPITE THE LONG AVAILABILITY OF VACCINES?

29/06/2026

News

Tính ổn định của vắc xin thủy đậu thế hệ 2 chủng MAV/06 – Barycela: Giá trị từ dữ liệu khoa học đến thực hành tiêm chủng

26/06/2026

News

ONE NAVIVA – A Journey of Unity, Appreciation, and Sustainable Growth

11/05/2026

News

WARNING OF RAPID VARICELLA TRANSMISSION AMONG YOUNG CHILDREN, EXPERTS RECOMMEND EARLY VACCINATION

26/06/2026

News

Chương trình đào tạo B2B Sales Master 2026

11/05/2026

News

VARICELLA SHOULD NOT BE UNDERESTIMATED, PHYSICIANS WARN OF SERIOUS COMPLICATIONS

11/05/2026

News

VARICELLA IS NOT A “MILD” DISEASE AND CAN CAUSE SERIOUS COMPLICATIONS

18/03/2026

News

The MAV/06 strain varicella vaccine reinforces immunity in children with a prior history of varicella infection

24/06/2026

News

Bài phát biểu của Chủ tịch & CEO – Bs. Lê Phước Thi tại đêm Gala Dinner nhân dịp kỷ niệm 20 năm thành lập NAVIVA Nam Hưng Việt và 22 năm thành lập NAVIVA Tường Khuê ngày 19/06/2026 tại Tp. Nha Trang

13/02/2026

News

Naviva Group Organizes a Scientific Conference Series to Update on Advancements in Varicella Prevention Derived from the MAV/06 Strain

21/01/2026

News

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

06/01/2026

News

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

24/12/2025

News

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

18/12/2025

News

Important improvements with the Barycela vaccine – The key to WHO-PQ

23/12/2025

News

Building Corporate Culture as a Foundation for Sustainable Development

16/12/2025

News

Barycela chickenpox vaccine – a suitable and reliable choice

29/12/2025

News

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

24/09/2025

News

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

06/05/2026

News

VA-MENGOC BC Vaccine – An Effective Solution for the Prevention of Meningococcal Meningitis

16/04/2026

News

News

NAVIVA Group tăng cường kết nối hợp tác cùng Viện Vắc xin và Sinh phẩm Y tế (IVAC)

CONGRATULATIONS ON THE 20TH ANNIVERSARY OF NAM HUNG VIET VACCINE AND BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

Scientific Symposium Highlights the Latest Recommendations on Varicella Prevention and the Second-Generation MAV/06 Varicella Vaccine

Scientific Symposium: VARICELLA – SECOND-GENERATION MAV/06 VACCINE AND UPDATES FROM THE WORLD HEALTH ORGANIZATION (WHO)

WHY ARE VARICELLA-RELATED HOSPITALISATIONS STILL INCREASING DESPITE THE LONG AVAILABILITY OF VACCINES?

Tính ổn định của vắc xin thủy đậu thế hệ 2 chủng MAV/06 – Barycela: Giá trị từ dữ liệu khoa học đến thực hành tiêm chủng

ONE NAVIVA – A Journey of Unity, Appreciation, and Sustainable Growth

WARNING OF RAPID VARICELLA TRANSMISSION AMONG YOUNG CHILDREN, EXPERTS RECOMMEND EARLY VACCINATION

Chương trình đào tạo B2B Sales Master 2026

VARICELLA SHOULD NOT BE UNDERESTIMATED, PHYSICIANS WARN OF SERIOUS COMPLICATIONS

VARICELLA IS NOT A “MILD” DISEASE AND CAN CAUSE SERIOUS COMPLICATIONS

The MAV/06 strain varicella vaccine reinforces immunity in children with a prior history of varicella infection

Bài phát biểu của Chủ tịch & CEO – Bs. Lê Phước Thi tại đêm Gala Dinner nhân dịp kỷ niệm 20 năm thành lập NAVIVA Nam Hưng Việt và 22 năm thành lập NAVIVA Tường Khuê ngày 19/06/2026 tại Tp. Nha Trang

Naviva Group Organizes a Scientific Conference Series to Update on Advancements in Varicella Prevention Derived from the MAV/06 Strain

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

Important improvements with the Barycela vaccine – The key to WHO-PQ

Building Corporate Culture as a Foundation for Sustainable Development

Barycela chickenpox vaccine – a suitable and reliable choice

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

VA-MENGOC BC Vaccine – An Effective Solution for the Prevention of Meningococcal Meningitis

VARICELLA AND THE BARYCELA VACCINE FROM SOUTH KOREA

Community’s Health Is Our Happiness!